Global Med Technologies(R), Inc. to Report Fourth Quarter and Year End Financial Results on Wednesday, March 25, 2009
March 10 2009 - 9:00AM
PR Newswire (US)
Conference Call to Follow Release DENVER, March 10
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will report its fourth quarter and year end financial results on
Wednesday, March 25, 2009, after the market closes. The Company
will host a conference call at 4:30 p.m. Eastern on the same day.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President
and Chief Operating Officer, and Karen Davis, Chief Financial
Officer, will discuss the fourth quarter and year end financial
results, as well as major company developments, and will be
available to answer questions. The conference call will be held on
March 25, 2009, at 4:30 p.m. Eastern. Interested parties are
welcome to call the telephone numbers listed below five minutes
prior to the start of the conference call. Callers within the U.S.
should call: 1-866-394-9731. Callers that are outside of the U.S.
should call: 1-706-643-7541. Callers should reference "Global Med
Fourth Quarter and Year End Financial Results" to the conference
call operator. The conference call ID number will be: 89705783. An
automated replay of the conference call will be available from
March 25, 2009 at 5:30 p.m. Eastern until March 27, 2009 at 11:59
p.m. Eastern. To access the replay, callers within the U.S. should
call: 1-800-642-1687. Callers outside of the U.S. should call:
1-706-645-9291 and enter Global Med's access code of 89705783. The
replay of the conference call will be available from March 27, 2009
onward at Global Med's website at http://www.globalmedtech.com/.
About Global Med Technologies(R), Inc. Global Med Technologies,
Inc. is an international medical software company which develops
regulated and non-regulated products and services for the
healthcare industry. As a leading provider of blood and laboratory
systems and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's domestic companies are Wyndgate
Technologies(R), a leader in software products and services for
donor centers and hospital transfusion services; eDonor(R), which
offers web-based donor relationship management systems; and
PeopleMed(TM), Inc., which implements cost-effective software
validation, consulting and compliance solutions to hospitals and
donor centers. Global Med's European subsidiary, Inlog, SA, is a
leading developer of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. For more information about Global Med's products
and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., +1-303-238-2000, , or
Investors, Karen Davis, CFO, +1-916-404-8495, , both of Global Med
Technologies, Inc. Web Site: http://www.globalmedtech.com/
Copyright